From FFPE to Biomarkers: High-Throughput Proteomics for Cancer Research
Formalin-fixed paraffin-embedded (FFPE) samples are essential for retrospective clinical research but present challenges for LC-MS proteomics.
This webinar introduces a streamlined, scalable workflow that simplifies FFPE sample preparation, enhancing efficiency and reproducibility for large-cohort studies and unlocking new opportunities for high-throughput biomarker discovery.
Our expert speakers will present data from diverse cancer samples, demonstrating robust and reproducible peptide and protein identification. They’ll outline how this approach improves high-throughput biomarker discovery by LC-MS and enables large-scale disease research using FFPE specimens.
Attend this webinar to:
- Recognize the challenges of FFPE proteomics and learn how to overcome analytical hurdles for reliable LC-MS analysis
- Understand how a streamlined, high-throughput workflow improves reproducibility in clinical research
- Learn how enhanced FFPE proteomics workflows accelerate biomarker discovery in large-cohort cancer studies
- Explore the role of BeatBox® and iST technology in simplifying FFPE sample processing
Presenter: Silvia Wuertenberger, PhD (Senior Product Manager, PreOmics)
Silvia Würtenberger joined PreOmics in 2022 as Product Manager for BeatBox. She interacts with customers and internal teams alike to provide customers with the best possible product solution for their needs in sample preparation. She holds a PhD in Biology from Eberhard-Karls-University Tübingen and is an expert in protein biochemistry and analytical technologies to measure protein attributes in vitro and in cellular contexts. Prior to PreOmics, Silvia gained experience in commercialization and development of biophysical tools for drug discovery at NanoTemper Technologies.
Presenter: Jessica Moore, PhD (Senior Scientist, Discovery Life Sciences)
Dr. Jessica Moore is passionate about proteomics and its potential to improve human health. She is currently a Huntsville Alabama-based Senior Scientist at Discovery Life Sciences, where she focuses on sample preparation approaches and non-invasive biomarker discovery. She is dedicated to helping collaborators use novel technologies and multiomics to study biological systems, furthering our understanding of disease progression, prognostics, and mechanisms of actions. Her background is in analytical chemistry. She graduated from Murray State University in 2009 with a B.S. in Chemistry and Music and earn an M.S in Analytical Chemistry before completing her doctorate at Vanderbilt University in 2016. With 14 years of experience in mass spectrometry, she has worked in diverse teams of scientists, pathologists, clinicians, and researchers.
